McEwen Inc. MUX 深 滬
等待開盤 03-26 09:30:00 美东时间
19.44
+0.500
+2.64%
華盛通- 最 高20.07
- 今 開20.07
- 成交量 75.00万股
- 最 低 19.22
- 昨 收 18.94
- 總市值 11.51亿
- 52周最高 29.70
- 市盈率 靜 37.01
- 換手率 1.27%
- 52周最低 6.38
- 委 比 4.62%
- 總股本 5921.84万
- 歷史最高 68.85
- 量 比 0.44
- 振 幅 4.49%
- 歷史最低 3.20
- 每 手 1
- 風險率 6.34%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多McEwen Eyes Up to 300K Gold Output by 2030 With New Tartan Mine Resource
McEwen Inc. (NYSE/TSX:MUX) ("McEwen" or the "Company") is pleased to report its Mineral Resource Estimate for the Tartan Mine Project, located in Flin Flon, Manitoba. The Mineral Resource Estimate outlines 308,900
03-23 18:16
McEwen Reports Tartan Mine Project Gold Mineral Resource Estimate
McEwen Inc. reports a Mineral Resource Estimate for the Tartan Mine Project in Manitoba, detailing 308,900 indicated gold ounces and 302,700 inferred gold ounces at a $3,000/oz gold price. Recent drilling highlights potential resource expansion around the Main and South Zones, with an exploration budget of $6 million in 2026. The company aims to double production to 250,000-300,000 ounces by 2030, targeting initial production of 30,000 ounces ann...
03-23 10:00
美股大行评级 | 超多下调！露露乐蒙、Oklo、腾讯音乐、Docusign、BOBS、Bicycle、Academy Sports等遭多家大行下调目标价
今日重点评级关注：花旗：维持Candel Therapeutics"买入"评级，目标价从22美元升至26美元；Chardan Capital：维持CervoMed"买入"评级，目标价从15美元升至21美元
03-19 14:31
Roth Capital Maintains Buy on McEwen, Raises Price Target to $35
Roth Capital analyst Joe Reagor maintains McEwen (NYSE:MUX) with a Buy and raises the price target from $30 to $35.
03-19 01:15
McEwen Mining Discloses Brief Annual Report Delay
McEwen Mining ( ($MUX) ) has released a notification of late filing. McEwen Inc...
03-17 22:22
Structure Therapeutics rises on mid-stage data for oral GLP-1
Structure Therapeutics (GPCR) is ~8% in Monday trading after reporting promising topline phase 2 data on its oral GLP-1 receptor agonist, aleniglipron, for obesity. Data was from the 44-week ACCESS II...
03-17 00:27
Earnings Scheduled For March 12, 2026
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
McEwen Q4 net income hits USD 38.1 million as adjusted EBITDA rises 138% to USD 28.1 million
McEwen Q4 net income hits USD 38.1 million as adjusted EBITDA rises 138% to USD 28.1 million McEwen reported Q4 net income of USD 38.1 million, compared with a net loss a year earlier, as revenue rose 28% to USD 64.6 million on sales of 15,196 gold equivalent ounces, supported by higher realized gol
03-12 18:02
McEwen Mining Q4 EPS $0.70 Beats $0.22 Estimate, Sales $64.600M Miss $71.301M Estimate
McEwen Mining (NYSE:MUX) reported quarterly earnings of $0.70 per share which beat the analyst consensus estimate of $0.22 by 218.18 percent. This is a 537.5 percent increase over losses of $(0.16) per share from the
03-12 18:01
McEwen Q4 and Year-End 2025 Results Conference Call
McEwen Inc. (NYSE/TSX: MUX)邀请投资者参加将于2026年3月12日下午3点EDT举行的2025年第四季度及年度财务会议。会上，管理层将讨论财务结果和项目进展，并回答问题。参与者可通过电话（北美免费：(888) 210-3454，国际：(646) 960-0130）或网络链接加入会议。McEwen专注于美洲地区的黄金、白银和铜矿项目，拥有位于阿根廷的大型Los Azules铜矿开发项目，并计划于2038年前实现碳中和。公司还投资于PhotonAssay™技术，并由Rob McEwen领导，致力于提升股东价值。
03-09 16:57
